Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Apr 15, 2015 5:36pm
121 Views
Post# 23634012

RE:RE:RE:RE:Lesson from ESPR

RE:RE:RE:RE:Lesson from ESPR
pickupstix,  i find you quite funny and entertaining, i am not attacking you..but isBTI like pre-pre-pre-clinical???? now that is way too funny...i just checked BTI had $0 rev and has a   $60M market cap...i understand they pay you for summin so you are "captive" but really you drank the Koolaid and has it been around for 8+ years or so..cmon that is funny by any standard except i guess for the pumpers  PS i ain't bashing BTI it is just beyond completely hilarious for anyone to attack RVX and defend BTI when they both are nuttin by crxp shoots (true believers, pumpertrasholes and fraudsters not withstanding)...keep the entertainment coming i find you much more preferable to leftcoast and that outed fraudster hoity toity (making up fake NR's that he claimed were from RVX)
Bullboard Posts